EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks

Haocong Qian, Yuxuan Zheng

Frontiers in Microbiology · 24.03.2026 · 17

DOI: 10.3389/fmicb.2026.1762768 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Frontiers in Microbiology, online erschienen am 24.03.2026. Verfasst von Haocong Qian und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, Fudan University, Shanghai, China. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 168 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Phage endolysins are increasingly recognized as alternatives to antibiotics for mitigating the growing threat of antimicrobial resistance. Since their initial identification in the 1950s, phage endolysins have been extensively demonstrated to effectively combat bacterial infections in animal models and human patients. Although phage endolysins have completed Phase II and III clinical trials, potential obstacles and challenges associated with their large-scale use remain largely undefined. This review examines the potential of phage endolysins and the challenges they face in addressing infections caused by antibiotic-resistant bacteria in the future. We conducted a comprehensive overview of the historical development, bactericidal mechanisms, clinical progress, and resistance of phage endolysins. The information presented herein may facilitate the design of novel, potent endolysins and provide strategic insights for addressing phage endolysin resistance.

Schlagwörter

Stichwörter der Autor:innen

antibiotic alternativesantimicrobial resistancephage endolysin resistancephage endolysinsphage therapy

Autor:innen und Institutionen

  • School of Life Sciences, Fudan University, Shanghai, China.
  • Human Phenome Institute, Pudong Hosptial, Fudan University, Shanghai, China.

Zitieren

APA

Qian, H., & Zheng, Y. (2026). Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks. Frontiers in Microbiology, 17. https://doi.org/10.3389/fmicb.2026.1762768

Vancouver

Qian H, Zheng Y. Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks. Frontiers in Microbiology. 2026;17. doi:10.3389/fmicb.2026.1762768

BibTeX
@article{Qian2026,
  author = {Qian, Haocong and Zheng, Yuxuan},
  title = {Phage endolysins as alternative antimicrobials: mechanisms, clinical progress, and emerging resistance frameworks},
  journal = {Frontiers in Microbiology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fmicb.2026.1762768}
}
Kostenlos starten →